Resources
A wide range of informative monographs, booklets and newsletters; all developed in-house by Cipla.
View allHey there! Welcome!
Get updated on
Select Speciality
Key Trials
Suppression of Frequently Recurrent Herpes Labialis with Oral Acyclovir
Acyclovir has been shown to be effective in suppressing recurrent herpes labialis in immunocompromised as well as immunocompetent hosts. The study confirmed that Oral Acyclovir 400 mg twice daily can effectively suppress herpes labialis in immunocompetent adults, thereby reducing both clinical and virus culture-positive recurrences compared to placebo therapy.
Spotlight
Slide Library
Tocilizumab-Cured Acute Necrotizing Encephalopathy Caused by Influenza A Virus
A 2-year-10-month-old boy with fever, vomiting, and limb shaking was diagnosed with influenza A-induced acute necrotizing encephalopathy. The condition worsened to a coma with abnormal reflexes. Treatment with tocilizumab (12 mg/kg), antiviral (oseltamivir), and supportive care led to clinical, laboratory, and radiological improvement. Full neurological recovery occurred within 2 months.
Patient Education
View all
